Precision diabetes: Where do we stand today?
作者信息
Mohan Viswanathan, Unnikrishnan Ranjit
机构信息
Madras Diabetes Research Foundation, ICMR Centre for Advanced Research on Diabetes, Dr Mohan's Diabetes Specialities Centre, WHO Collaborating Centre for Non-communicable Disease Prevention & Control & IDF Centre of Excellence in Diabetes Care, No. 4, Conran Smith Road, Gopalapuram, Chennai 600 086, Tamil Nadu, India.
出版信息
Indian J Med Res. 2018 Nov;148(5):472-475. doi: 10.4103/ijmr.IJMR_1628_18.
Abstract
摘要
相似文献
1
Precision diabetes: Where do we stand today?精准糖尿病：我们如今处于什么位置？
Indian J Med Res. 2018 Nov;148(5):472-475. doi: 10.4103/ijmr.IJMR_1628_18.
2
Diabetes Mellitus: A Perspective on the Post-Insulin Era.糖尿病：胰岛素时代后的展望。
Mayo Clin Proc. 2020 Jan;95(1):15-21. doi: 10.1016/j.mayocp.2019.11.016.
3
Precision Diabetes Is Slowly Becoming a Reality.精准糖尿病治疗正逐渐成为现实。
Med Princ Pract. 2019;28(1):1-9. doi: 10.1159/000497241. Epub 2019 Jan 27.
4
Precision medicine in diabetes.糖尿病精准医学
J Pak Med Assoc. 2019 Sep;69(9):1394-1395.
5
Discovery of genetic biomarker that could improve the treatment of diabetes.发现可改善糖尿病治疗的基因生物标志物。
Pharmacogenomics. 2009 Aug;10(8):1217. doi: 10.2217/pgs.09.98.
6
Cystic fibrosis in the era of precision medicine.精准医学时代的囊性纤维化
Paediatr Respir Rev. 2018 Jan;25:64-72. doi: 10.1016/j.prrv.2017.03.001. Epub 2017 Mar 9.
7
Precision medicine for managing diabetes.糖尿病管理的精准医学
J Diabetes Sci Technol. 2015 Jan;9(1):3-7. doi: 10.1177/1932296814563643.
8
Moving towards a more precise treatment of diabetes.迈向更精准的糖尿病治疗。
Lancet Diabetes Endocrinol. 2015 Mar;3(3):171. doi: 10.1016/S2213-8587(15)00010-8.
9
Personalized medicine in diabetes mellitus: current opportunities and future prospects.糖尿病个性化医疗：当前机遇与未来前景
Ann N Y Acad Sci. 2015 Jun;1346(1):45-56. doi: 10.1111/nyas.12757. Epub 2015 Apr 23.
10
Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.药物基因组学和药物遗传学指导治疗作为精准医学中的一种工具：现状及影响利益相关者接受度的因素。
Genet Res (Camb). 2015 Jun 1;97:e13. doi: 10.1017/S0016672315000099.
引用本文的文献
1
Challenges Involved in Incorporating Personalised Treatment Plan as Routine Care of Patients with Diabetes.将个性化治疗方案纳入糖尿病患者常规护理所涉及的挑战。
Pharmgenomics Pers Med. 2021 Mar 16;14:327-333. doi: 10.2147/PGPM.S271582. eCollection 2021.
本文引用的文献
1
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.KCNJ11 基因突变致新生儿糖尿病患者磺脲类药物长期治疗的有效性和安全性：一项国际队列研究。
Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646. doi: 10.1016/S2213-8587(18)30106-2. Epub 2018 Jun 4.
2
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.基于六个变量的聚类分析：成人发病型糖尿病的新型亚组及其与结局的关系
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369. doi: 10.1016/S2213-8587(18)30051-2. Epub 2018 Mar 5.
3
Continuous glucose monitoring: transforming diabetes management step by step.持续血糖监测：逐步改变糖尿病管理方式。
Lancet. 2018 Apr 7;391(10128):1334-1336. doi: 10.1016/S0140-6736(18)30290-3. Epub 2018 Feb 16.
4
Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India.综合基因组分析鉴定了印度南部年轻起病的成年型糖尿病（MODY）患者中的致病性变异。
BMC Med Genet. 2018 Feb 13;19(1):22. doi: 10.1186/s12881-018-0528-6.
5
Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy.2 型糖尿病的精准医疗：胰岛素抵抗的临床标志物与 DPP-4 抑制剂治疗的短期和长期血糖反应改变相关。
Diabetes Care. 2018 Apr;41(4):705-712. doi: 10.2337/dc17-1827. Epub 2018 Jan 31.
6
A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.一项关于即时血糖监测对 1 型和 2 型糖尿病患者血糖控制影响的多中心真实世界研究。
Diabetes Technol Ther. 2017 Sep;19(9):533-540.
7
Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study.血清素转运体5-HTTLPR基因多态性对二甲双胍胃肠道不耐受的影响：一项GoDARTS研究
Diabetes Care. 2016 Nov;39(11):1896-1901. doi: 10.2337/dc16-0706. Epub 2016 Aug 4.
8
CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes.CYP2C8 和 SLCO1B1 变体与 2 型糖尿病患者噻唑烷二酮类药物治疗反应的关系。
Diabetes Care. 2016 Nov;39(11):1902-1908. doi: 10.2337/dc15-2464. Epub 2016 Jun 6.
9
A new initiative on precision medicine.一项关于精准医学的新倡议。
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
10
Novel ABCC8 (SUR1) gene mutations in Asian Indian children with congenital hyperinsulinemic hypoglycemia.亚洲印度裔先天性高胰岛素血症性低血糖儿童中的新型ABCC8（SUR1）基因突变
Ann Hum Genet. 2014 Sep;78(5):311-9. doi: 10.1111/ahg.12070.
Zotero 插件